LYEL – lyell immunopharma, inc. (US:NASDAQ)
Stock Stats
News
LB Pharmaceuticals Names Heather Turner as CEO to Lead its Development of Transformative Advances in Schizophrenia Treatment [Yahoo! Finance]
Lyell Immunopharma (LYEL) Upgraded to Buy: Here's What You Should Know [Yahoo! Finance]
Avalyn Appoints Heather Turner, J.D., Biopharma Industry Veteran, as Chair of its Board of Directors [Yahoo! Finance]
Lyell Immunopharma, Inc. (NASDAQ: LYEL) had its "neutral" rating re-affirmed by analysts at HC Wainwright. They now have a $1.00 price target on the stock.
Lyell Immunopharma Reports Business Highlights and Financial Results for the Third Quarter 2024
Form SC 13G/A Lyell Immunopharma, Inc. Filed by: VANGUARD GROUP INC
Form 10-Q Lyell Immunopharma, Inc. For: Sep 30
Form 8-K Lyell Immunopharma, Inc. For: Nov 07
Form SC 13G/A Lyell Immunopharma, Inc. Filed by: VANGUARD GROUP INC
Form 4 Lyell Immunopharma, Inc. For: Oct 31 Filed by: Ramachandra Sumant
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.